VCLN $22.12 0%
MRSN $7.94 -0.6884%
8148.HK $0.08 -10.989%
MITT-PA $17.00 0%
FTII $10.54 0%
IWML $14.43 -2.0918%
ALQP.PA $19.90 0%
MGEE $77.91 0.6589%
QDIV $30.45 -0.2486%
0QF8.L $9.34 -2.9106%
LUV $28.45 -1.795%
2048.HK $0.39 -1.2658%
WNWD.L $45.00 0%
SOI.PA $127.10 -4.6869%
DGICB $14.69 0%
VEN2.L $90.50 0%
7226.HK $4.67 0.1286%
CTEK.L $9.70 2.628%
1525.HK $4.00 4.1667%
0048.HK $0.29 0%
8032.HK $1.29 0.7812%
SMTI $41.30 3.2758%
NDP $27.57 0.1766%
RAIL3.SA $20.80 -0.1919%
OSK $72.97 -0.856%
SPAK $14.63 0%
NVDE.L $120.07 1.1925%
GJT $21.63 0.1853%
IRBT $33.80 -1.1696%
8107.HK $1.21 3.4188%
0RS2.L $49.50 -0.4112%
BENE.L $31.27 -5.9549%
2288.HK $0.35 1.4493%
BRF $15.17 -0.0659%
ARM.MC $8.00 0%
RYAN $43.10 -0.3699%
HAMA.L $8.80 -2.2222%
CVT.NZ $2.93 0%
FNHC $0.00 -87.5%
0Y5C.L $108.87 0.8429%
CRK $9.72 4.1265%
VLYPO $16.48 -1.0804%
NAK $0.23 -0.1767%
MCLD $0.33 14.1152%
1875.HK $2.65 -3.6364%
HCDIP $5.45 4.2065%
FAII $10.28 0%
0HB0.L $27.83 0%
KIIIW $0.00 0%
HNVR $18.00 0.3697%
ME $2.02 -4.0476%
NRZ $10.89 0%
0IJ2.L $76.89 -0.0911%
8096.HK $0.26 -3.7736%
LVRAW $0.04 -13.0435%
O2IBS.PA $0.08 0%
VERV $17.33 -4.5454%
KEMX $25.07 -0.6798%
ISJP.L $3 132.00 0.9671%
VLN $2.38 -4.6185%
SIGC.L $53.50 0%
AGTI $15.92 -3.5736%
ASLEW $6.48 0%
CEI $1.16 -4.0496%
SR-PA $24.84 -0.0604%
JMI.L $276.00 -0.1808%
9810.HK $9.04 -0.1657%
EWZS $13.04 0.4623%
DS-PB $8.03 -8.22857%
2310.HK $0.09 1.17647%
0KRX.L $78.32 -1.8436%
VSDA $44.64 -0.478%
LFG $26.00 0%
ENET.L $2.80 -9.0909%
FLLV $46.82 -0.4677%
1293.HK $0.35 1.4493%
2033.HK $0.40 0%
WVAL.L $25.62 0.1955%
IHE $178.49 -0.7048%
FLUX.BR $29.10 -1.3559%
GWRS $11.03 -0.7201%
0124.HK $0.80 -1.2346%
0Q4C.L $25.60 -6.2271%
DJCO $272.30 0.1545%
NGRD3.SA $1.37 -5.5172%
ANAB $19.05 -8.2611%
GCLE.L $23.71 0.5514%
GGPI $11.23 0%
WIX $75.25 -3.0783%
0QNU.L $73.80 -2.122%
TCRR $1.93 -1.5306%
MONCW $0.00 0%
GAINM $25.03 0%
NEXA $5.90 -0.1692%
HGSH $3.02 0%
AUEG.L $372.25 -0.3614%
KRA $46.49 0%
SACH $3.34 0.1502%
0P000185T3.L $22 169.70 0.1079%
Eng
Логотип
Eng
Лого

Agios Pharmaceuticals, Inc. 0HB0.L

$27.83

На 18:02, 12 мая 2023

Ключевые показатели

  • Marketcap

    12651582.00000000

  • week52high

    0.00

  • week52low

    0.00

  • Revenue

  • P/E TTM

    0

  • Beta

    0.95328700

  • EPS

    -6.42600000

  • Last Dividend

    0.28500000

  • Next Earnings Date

    04 мая 2023 г. в 12:00

Описание компании

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек